Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Zappa

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
Preventive Medicine|June 5, 2013
Screening patterns within organized programs and survival of Italian women with invasive cervical cancerAntonella Zucchetto, Guglielmo Ronco, Paolo Giorgi Rossi, et al.
European Urology|April 23, 2023
Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate CancerSebastiaan Remmers, Chris H Bangma, Rebecka A Godtman, et al.
The New England Journal of Medicine|October 29, 2025
European Study of Prostate Cancer Screening - 23-Year Follow-upMonique J Roobol, Ivo I de Vos, Marianne Månsson, et al.
Annals of Internal Medicine|September 5, 2017
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO TrialsAlex Tsodikov, Roman Gulati, Eveline A M Heijnsdijk, et al.
Surgical Endoscopy|April 1, 2010
Laparoscopic adjustable gastric banding via pars flaccida versus perigastric positioning: technique, complications, and results in 2,549 patientsNicola Di Lorenzo, Francesco Furbetta, Franco Favretti, et al.
The New England Journal of Medicine|March 20, 2009
Screening and prostate-cancer mortality in a randomized European studyFritz H Schröder, Jonas Hugosson, Monique J Roobol, et al.
Cancer|December 7, 2017
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trialsHarry J de Koning, Roman Gulati, Sue M Moss, et al.
The New England Journal of Medicine|August 17, 2012
Quality-of-life effects of prostate-specific antigen screeningEveline A M Heijnsdijk, Elisabeth M Wever, Anssi Auvinen, et al.
European Urology|August 8, 2009
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Monique J Roobol, Melissa Kerkhof, Fritz H Schröder, et al.
Wellcome Open Research|September 16, 2020
Half a Century of Wilson & Jungner: Reflections on the Governance of Population ScreeningSteve Sturdy, Fiona Miller, Stuart Hogarth, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Preventive Medicine|June 5, 2013
Screening patterns within organized programs and survival of Italian women with invasive cervical cancerAntonella Zucchetto, Guglielmo Ronco, Paolo Giorgi Rossi, et al.
European Urology|April 23, 2023
Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate CancerSebastiaan Remmers, Chris H Bangma, Rebecka A Godtman, et al.
The New England Journal of Medicine|October 29, 2025
European Study of Prostate Cancer Screening - 23-Year Follow-upMonique J Roobol, Ivo I de Vos, Marianne Månsson, et al.
Annals of Internal Medicine|September 5, 2017
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO TrialsAlex Tsodikov, Roman Gulati, Eveline A M Heijnsdijk, et al.
Surgical Endoscopy|April 1, 2010
Laparoscopic adjustable gastric banding via pars flaccida versus perigastric positioning: technique, complications, and results in 2,549 patientsNicola Di Lorenzo, Francesco Furbetta, Franco Favretti, et al.
The New England Journal of Medicine|March 20, 2009
Screening and prostate-cancer mortality in a randomized European studyFritz H Schröder, Jonas Hugosson, Monique J Roobol, et al.
Cancer|December 7, 2017
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trialsHarry J de Koning, Roman Gulati, Sue M Moss, et al.
The New England Journal of Medicine|August 17, 2012
Quality-of-life effects of prostate-specific antigen screeningEveline A M Heijnsdijk, Elisabeth M Wever, Anssi Auvinen, et al.
European Urology|August 8, 2009
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Monique J Roobol, Melissa Kerkhof, Fritz H Schröder, et al.
Wellcome Open Research|September 16, 2020
Half a Century of Wilson & Jungner: Reflections on the Governance of Population ScreeningSteve Sturdy, Fiona Miller, Stuart Hogarth, et al.
Pageof 22